$0.13-0.01 (-6.53%)
News25/Ratings0
Price$0.13-0.01 (-4.57%)
01:30 PM07:45 PM
News · 26 weeks56+9%
2025-11-022026-04-26
Mix3190d
- SEC Filings13(42%)
- Market11(35%)
- Insider5(16%)
- Other2(6%)
Latest news
25 items- SECAmendment: SEC Form 10-K/A filed by Wellgistics Health Inc.10-K/A - Wellgistics Health, Inc. (0002030763) (Filer)
- SECSEC Form PRE 14A filed by Wellgistics Health Inc.PRE 14A - Wellgistics Health, Inc. (0002030763) (Filer)
- INSIDERChief Executive Officer Patel Prashant was granted 5,000,000 shares, increasing direct ownership by 121% to 9,118,247 units (SEC Form 4)4 - Wellgistics Health, Inc. (0002030763) (Issuer)
- INSIDERDirector Ajjarapu Surendra K was granted 5,000,000 shares, increasing direct ownership by 173% to 7,882,247 units (SEC Form 4)4 - Wellgistics Health, Inc. (0002030763) (Issuer)
- SECAmendment: Wellgistics Health Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K/A - Wellgistics Health, Inc. (0002030763) (Filer)
- SECWellgistics Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Wellgistics Health, Inc. (0002030763) (Filer)
- SECSEC Form S-3 filed by Wellgistics Health Inc.S-3 - Wellgistics Health, Inc. (0002030763) (Filer)
- NEWSWellgistics Health and Kare PharmTech Execute Joint Venture Expanding Access to 200,000+ Patient LivesJoint venture executed combining Wellgistics Hub and KareRx Hub technology and operationsIntegrated platform accelerates pharmaceutical access, fulfillment, and commercializationCombined ecosystem provides potential reach to an estimated 200,000+ patient lives across pharmaceutical and provider networksTAMPA, FL / ACCESS Newswire / April 14, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics" or the "Company"), a leading healthcare technology and pharmaceutical distribution company, today announced the execution of a definitive joint venture agreement with Kare PharmTech's wholly owned subsidiary, Kare Rx Hub, LLC ("KareRx"), an artificial intelligence (AI)-driven digital hub suppor
- INSIDERSEC Form 3 filed by new insider Herman Gary L3 - Wellgistics Health, Inc. (0002030763) (Issuer)
- INSIDERSEC Form 3 filed by new insider Sherb Eric Michael3 - Wellgistics Health, Inc. (0002030763) (Issuer)
- SECWellgistics Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Other Events8-K - Wellgistics Health, Inc. (0002030763) (Filer)
- SECWellgistics Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Unregistered Sales of Equity Securities, Financial Statements and Exhibits8-K - Wellgistics Health, Inc. (0002030763) (Filer)
- SECSEC Form DEF 14C filed by Wellgistics Health Inc.DEF 14C - Wellgistics Health, Inc. (0002030763) (Filer)
- INSIDERSEC Form 3 filed by new insider Velez Marlene3 - Wellgistics Health, Inc. (0002030763) (Issuer)
- SECSEC Form PRER14C filed by Wellgistics Health Inc.PRER14C - Wellgistics Health, Inc. (0002030763) (Filer)
- NEWSWellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric DisordersTAMPA, FL / ACCESS Newswire / March 23, 2026 / Wellgistics Health, Inc. ("Wellgistics" or the "Company") (NASDAQ:WGRX) today announced that it has entered into a non-exclusive, non-binding Letter of Intent ("LOI") to evaluate a potential acquisition of Neuritek Therapeutics, a neuroscience-focused research organization.The proposed all stock transaction, if completed, is intended to enhance Wellgistics' existing revenue-generating healthcare platform by expanding capabilities adjacent to its core technology-enabled pharmacy distribution and services business. Through its integrated ecosystem spanning prescription fulfillment, wholesale distribution, and AI-driven patient access solutions, We
- SECSEC Form 10-K filed by Wellgistics Health Inc.10-K - Wellgistics Health, Inc. (0002030763) (Filer)
- NEWSWellgistics Management Converts $2 Million in Deferred Compensation into Equity at $0.20 per ShareTAMPA, FL / ACCESS Newswire / March 19, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today announced that its President and Interim Chief Executive Officer, Prashant Patel, together with an additional participant from the Company's Board of Directors, entered into agreements with the Company to convert an aggregate of approximately $2.0 million of accrued compensation into shares of the Company's common stock at a conversion price of $0.20 per share, re
- NEWSWellgistics President Releases Letter to Shareholder on Emerging Patient Care-Centric Strategic DirectionTAMPA, FL / ACCESS Newswire / March 13, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ into its patented blockchain-enabled smart contracts platform PharmacyChain™, today announced that its President & Interim-CEO Prashant Patel, RPh released a letter to shareholders.The prescription drug and broader healthcare landscapes in the United States are rapidly changing. From the direct involvement of the federal government in providing discount cards for prescription drugs via to direct to consumers (DTC) online platform TrumpRx, to majo
- SECWellgistics Health Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure, Financial Statements and Exhibits8-K - Wellgistics Health, Inc. (0002030763) (Filer)
- NEWSWellgistics Strengthens PharmacyChain(TM) with Insurance Eligibility & Benefits Verification CapabilitiesMedical insurance eligibility and benefits verification (EBV) is a core health technology capability necessary for PharmacyChain™ to gain market adoptionEBV services offering enabled with preferred pricing being made immediately available to providers, partners and the Wellgistics Pharmacy NetworkEBV market expected to grow from $2.39 billion in 2025 to $3 billion in 2030 according to The Business Research Company1TAMPA, FL / ACCESS Newswire / March 11, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ into its patented blockchain-ena
- SECWellgistics Health Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits8-K - Wellgistics Health, Inc. (0002030763) (Filer)
- NEWSWellgistics Targets $70B Market Breakthrough Addressing Ozempic / GLP-1 Muscle Loss with Forzet(TM)GLP-1 agonist market expected to grow from $70B in 2025 to $201B in 20301Proprietary Forzet formulation provides pharmacists, physicians and patients with unique solution for GLP-1 drugs' primary side effectForzet targeting preservation of muscle while on GLP-1 agonist therapy to facilitate continued patient adherence and muscle redevelopment following therapy discontinuation to help mitigate weight regainTAMPA, FLORIDA / ACCESS Newswire / March 9, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics") , a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ into its patented blockchain-enabled
- NEWSWellgistics Health Selects Top Five Blockchain Platforms to Initiate Patent Protected PharmacyChain(TM) Smart Contracts-enabled Pharmaceutical Drug Tracking System to Support Industry-wide Serialization MandateHyperledger Fabric, Ethereum/Polygon, VeChain, Quorum /Besu and Corda (R3) selected as most suitable blockchain platforms to build PharmacyChain™U.S. prescription drugs market project to grow from $634 billion market to $883 billion by 2030 according to Grandview Research[1]Global blockchain in healthcare market is projected to grow from $11 billion in 2024 to $214 billion by 2030, according to Grandview Research[2]TAMPA, FLORIDA / ACCESS Newswire / March 5, 2026 / Wellgistics Health, Inc. (NASDAQ:WGRX) ("Wellgistics"), a health information technology leader, integrating proprietary pharmacy dispensing optimization artificial intelligence (AI) platform EinsteinRx™ into its patented blockchai
- NEWSDataVault AI and Wellgistics Health Announce Plans to Expand Partnership to Include Healthcare Delivery Intellectual Property for Healthcare as a Service (HaaS) Blockchain-enabled Smart ContractsThe global blockchain in healthcare market is projected to grow from $11 billion in 2024 to $214 billion by 2030, with annual growth rates expected to exceed 60%Ongoing PharmacyChain® technology build-out already involves key technology components necessary to enable Healthcare as a Service (HaaS) smart contractsDatavault AI partner programming capabilities included to speed market entryWellgistics' recently announced NFL Alumni Health partnership provides trusted marketing capability to help drive market awareness and adoptionWellgistics Pharmacy's online prescription fulfillment capability set to become primary distribution channel for prescription drugs and OTC health productsWellgistics